Sveja Eberhard

706 total citations
40 papers, 478 citations indexed

About

Sveja Eberhard is a scholar working on General Health Professions, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sveja Eberhard has authored 40 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in General Health Professions, 12 papers in Epidemiology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sveja Eberhard's work include Health and Medical Studies (11 papers), Chronic Disease Management Strategies (10 papers) and Social and Demographic Issues in Germany (8 papers). Sveja Eberhard is often cited by papers focused on Health and Medical Studies (11 papers), Chronic Disease Management Strategies (10 papers) and Social and Demographic Issues in Germany (8 papers). Sveja Eberhard collaborates with scholars based in Germany, Portugal and United States. Sveja Eberhard's co-authors include Siegfried Geyer, Jona T. Stahmeyer, Jelena Epping, Juliane Tetzlaff, Jelena Jaunzeme, Jan Zeidler, Karin Weißenborn, Lea de Jong, Kathrin Damm and Stefanie Sperlich and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Pharmacology.

In The Last Decade

Sveja Eberhard

40 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sveja Eberhard Germany 12 189 146 102 89 76 40 478
Anne Gilsing Canada 8 102 0.5× 98 0.7× 92 0.9× 83 0.9× 52 0.7× 14 373
Xenia Dolja‐Gore Australia 13 142 0.8× 59 0.4× 83 0.8× 140 1.6× 55 0.7× 59 530
Maja Barker Ireland 7 131 0.7× 67 0.5× 51 0.5× 135 1.5× 78 1.0× 8 485
Marie‐Rachelle Narcisse United States 14 203 1.1× 57 0.4× 117 1.1× 81 0.9× 47 0.6× 51 470
Tanveer Rehman India 11 99 0.5× 103 0.7× 66 0.6× 63 0.7× 33 0.4× 57 491
Annette Haywood United Kingdom 12 164 0.9× 61 0.4× 158 1.5× 53 0.6× 34 0.4× 21 493
Kaan Sözmen Türkiye 15 147 0.8× 59 0.4× 189 1.9× 59 0.7× 61 0.8× 43 566
Kay Miller United States 11 138 0.7× 148 1.0× 72 0.7× 27 0.3× 56 0.7× 29 503
Guedy Arniella United States 11 201 1.1× 85 0.6× 135 1.3× 36 0.4× 20 0.3× 22 467
Karin Festin Sweden 14 202 1.1× 66 0.5× 82 0.8× 37 0.4× 24 0.3× 28 513

Countries citing papers authored by Sveja Eberhard

Since Specialization
Citations

This map shows the geographic impact of Sveja Eberhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sveja Eberhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sveja Eberhard more than expected).

Fields of papers citing papers by Sveja Eberhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sveja Eberhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sveja Eberhard. The network helps show where Sveja Eberhard may publish in the future.

Co-authorship network of co-authors of Sveja Eberhard

This figure shows the co-authorship network connecting the top 25 collaborators of Sveja Eberhard. A scholar is included among the top collaborators of Sveja Eberhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sveja Eberhard. Sveja Eberhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eberhard, Sveja, et al.. (2023). Prävalenz des metabolischen Syndroms. Die Innere Medizin. 64(5). 482–489. 2 indexed citations
2.
Geyer, Siegfried, Juliane Tetzlaff, Stefanie Sperlich, et al.. (2023). Decreasing COPD-related incidences and hospital admissions in a German health insurance population. Scientific Reports. 13(1). 21293–21293. 1 indexed citations
3.
Jong, Lea de, et al.. (2022). Willingness to provide informal care to older adults in Germany: a discrete choice experiment. The European Journal of Health Economics. 24(3). 425–436. 14 indexed citations
4.
Eberhard, Sveja, Jona T. Stahmeyer, Anika Großhennig, et al.. (2021). Effectiveness of Trainings of General Practitioners on Antibiotic Stewardship: Methods of a Pragmatic Quasi-Experimental Study in a Controlled Before-After Design in South-East-Lower Saxony, Germany (WASA). Frontiers in Pharmacology. 12. 533248–533248. 3 indexed citations
5.
Jong, Lea de, Jona T. Stahmeyer, Sveja Eberhard, Jan Zeidler, & Kathrin Damm. (2021). Willingness and preparedness to provide care: interviews with individuals of different ages and with different caregiving experiences. BMC Geriatrics. 21(1). 207–207. 11 indexed citations
6.
Schneider, Nils, Birgitt Wiese, Jona T. Stahmeyer, et al.. (2020). Quality indicators for the evaluation of end-of-life care in Germany – a retrospective cross-sectional analysis of statutory health insurance data. BMC Palliative Care. 19(1). 187–187. 23 indexed citations
7.
Jong, Lea de, Jona T. Stahmeyer, Sveja Eberhard, Jan Zeidler, & Kathrin Damm. (2020). „Aber vielfach scheitert man dann an Besonderheiten“ – Pflegeberater über Gesetzesänderungen und die Herausforderungen ihrer Arbeit: Eine qualitative Untersuchung. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 150-152. 65–72. 4 indexed citations
8.
9.
Zeidler, Jan, Jona T. Stahmeyer, Sveja Eberhard, et al.. (2019). Claims Data Analysis on the Dispensing of Tricyclic Antidepressants Among Patients With Dementia in Germany. Frontiers in Pharmacology. 10. 841–841. 2 indexed citations
10.
Geyer, Siegfried, Juliane Tetzlaff, Sveja Eberhard, Stefanie Sperlich, & Jelena Epping. (2019). Health inequalities in terms of myocardial infarction and all-cause mortality: a study with German claims data covering 2006 to 2015. International Journal of Public Health. 64(3). 387–397. 7 indexed citations
11.
Stahmeyer, Jona T., et al.. (2019). The Frequency and Timing of Recurrent Stroke. Deutsches Ärzteblatt international. 116(42). 711–717. 46 indexed citations
12.
Riedel, Oliver, Christoph Ohlmeier, Albrecht Elsässer, et al.. (2018). The contribution of comorbidities to mortality in hospitalized patients with heart failure. Clinical Research in Cardiology. 107(6). 487–497. 25 indexed citations
13.
Tetzlaff, Juliane, Jelena Epping, Stefanie Sperlich, et al.. (2018). Widening inequalities in multimorbidity? Time trends among the working population between 2005 and 2015 based on German health insurance data. International Journal for Equity in Health. 17(1). 103–103. 25 indexed citations
14.
Zeidler, Jan, Stefan Neubauer, Mona Abdel‐Hamid, et al.. (2018). Continuity of treatment with benzodiazepines in dementia patients. International Clinical Psychopharmacology. 33(5). 282–289. 6 indexed citations
15.
Tetzlaff, Juliane, et al.. (2017). Expansion or compression of multimorbidity? 10-year development of life years spent in multimorbidity based on health insurance claims data of Lower Saxony, Germany. International Journal of Public Health. 62(6). 679–686. 28 indexed citations
16.
Eberhard, Sveja, et al.. (2017). Psychische Störungen im Erwerbsalter. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 60(12). 1346–1355. 2 indexed citations
17.
Jaunzeme, Jelena, Sveja Eberhard, & Siegfried Geyer. (2013). Wie „repräsentativ“ sind GKV-Daten?: Demografische und soziale Unterschiede und Ähnlichkeiten zwischen einer GKV-Versichertenpopulation, der Bevölkerung Niedersachsens sowie der Bundesrepublik am Beispiel der AOK Niedersachsen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 56(3). 447–454. 11 indexed citations
18.
Jaunzeme, Jelena, Sveja Eberhard, & Siegfried Geyer. (2013). Wie „repräsentativ“ sind GKV-Daten?. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 56(3). 447–454. 72 indexed citations
19.
Bernateck, Michael, et al.. (2009). Placebotherapie: Analyse von Umfang und Erwartung in einer Klinik der Maximalversorgung. Der Schmerz. 23(1). 47–53. 4 indexed citations
20.
Bernateck, Michael, et al.. (2008). Placebotherapie. Der Schmerz. 23(1). 47–53. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Gilsing Breakdown of academic impact, for papers by Xenia Dolja‐Gore Breakdown of academic impact, for papers by Maja Barker Breakdown of academic impact, for papers by Marie‐Rachelle Narcisse Breakdown of academic impact, for papers by Tanveer Rehman Breakdown of academic impact, for papers by Annette Haywood Breakdown of academic impact, for papers by Kaan Sözmen Breakdown of academic impact, for papers by Kay Miller Breakdown of academic impact, for papers by Guedy Arniella Breakdown of academic impact, for papers by Karin Festin
Rankless by CCL
2026